Company Filing History:
Years Active: 2005-2007
Title: Geza Tímári: Innovator in Adenosine A3 Ligands
Introduction
Geza Tímári is a notable inventor based in Vecsés, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of adenosine A3 receptor ligands. With a total of 2 patents to his name, Tímári's work has implications for various therapeutic applications.
Latest Patents
Tímári's latest patents include innovative compounds that serve as adenosine A3 receptor ligands. The first patent focuses on imidazoquinoline derivatives, which are described as antagonists and include their salts, solvates, and isomers. This invention outlines the preparation of these compounds and their potential pharmaceutical applications. The second patent involves aminoquinoline and aminopyridine derivatives, which are also strong adenosine A3 receptor ligands, preferably antagonists. These compounds are characterized by specific structural features that enhance their efficacy.
Career Highlights
Geza Tímári is currently associated with Sanofi-Aventis, a leading global biopharmaceutical company. His work at Sanofi-Aventis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in drug development.
Collaborations
Tímári has worked alongside notable colleagues such as László Balázs and Mária Balogh. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical compounds.
Conclusion
Geza Tímári's contributions to the field of medicinal chemistry, particularly in the area of adenosine A3 receptor ligands, highlight his role as an influential inventor. His patents reflect a commitment to advancing therapeutic options and improving patient outcomes.